vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $111.7M, roughly 1.1× ZIPRECRUITER, INC.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -0.7%, a 4.1% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 0.6%). ZIPRECRUITER, INC. produced more free cash flow last quarter ($7.6M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -4.4%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
ZipRecruiter, Inc. is an American employment marketplace for job seekers and employers.
NATR vs ZIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $111.7M |
| Net Profit | $4.1M | $-835.0K |
| Gross Margin | 72.5% | 89.1% |
| Operating Margin | 4.3% | 3.6% |
| Net Margin | 3.3% | -0.7% |
| Revenue YoY | 4.7% | 0.6% |
| Net Profit YoY | 1379.4% | 92.3% |
| EPS (diluted) | $0.23 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $111.7M | ||
| Q3 25 | $128.3M | $115.0M | ||
| Q2 25 | $114.8M | $112.2M | ||
| Q1 25 | $113.2M | $110.1M | ||
| Q4 24 | $118.2M | $111.0M | ||
| Q3 24 | $114.6M | $117.1M | ||
| Q2 24 | $110.6M | $123.7M | ||
| Q1 24 | $111.0M | $122.2M |
| Q4 25 | $4.1M | $-835.0K | ||
| Q3 25 | $5.3M | $-9.8M | ||
| Q2 25 | $5.3M | $-9.5M | ||
| Q1 25 | $4.7M | $-12.8M | ||
| Q4 24 | $-321.0K | $-10.8M | ||
| Q3 24 | $4.3M | $-2.6M | ||
| Q2 24 | $1.3M | $7.0M | ||
| Q1 24 | $2.3M | $-6.5M |
| Q4 25 | 72.5% | 89.1% | ||
| Q3 25 | 73.3% | 89.1% | ||
| Q2 25 | 71.7% | 89.3% | ||
| Q1 25 | 72.1% | 89.4% | ||
| Q4 24 | 72.0% | 89.6% | ||
| Q3 24 | 71.3% | 89.4% | ||
| Q2 24 | 71.4% | 89.5% | ||
| Q1 24 | 71.2% | 89.1% |
| Q4 25 | 4.3% | 3.6% | ||
| Q3 25 | 7.0% | -4.4% | ||
| Q2 25 | 3.7% | -5.9% | ||
| Q1 25 | 5.4% | -10.6% | ||
| Q4 24 | 3.8% | -3.6% | ||
| Q3 24 | 4.6% | -2.8% | ||
| Q2 24 | 5.1% | 7.6% | ||
| Q1 24 | 4.2% | -0.7% |
| Q4 25 | 3.3% | -0.7% | ||
| Q3 25 | 4.2% | -8.5% | ||
| Q2 25 | 4.6% | -8.5% | ||
| Q1 25 | 4.2% | -11.7% | ||
| Q4 24 | -0.3% | -9.7% | ||
| Q3 24 | 3.8% | -2.2% | ||
| Q2 24 | 1.2% | 5.7% | ||
| Q1 24 | 2.1% | -5.3% |
| Q4 25 | $0.23 | $-0.03 | ||
| Q3 25 | $0.30 | $-0.11 | ||
| Q2 25 | $0.28 | $-0.10 | ||
| Q1 25 | $0.25 | $-0.13 | ||
| Q4 24 | $-0.02 | $-0.10 | ||
| Q3 24 | $0.23 | $-0.03 | ||
| Q2 24 | $0.07 | $0.07 | ||
| Q1 24 | $0.12 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $188.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $-77.2M |
| Total Assets | $261.1M | $569.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $188.0M | ||
| Q3 25 | $95.6M | $211.8M | ||
| Q2 25 | $81.3M | $203.5M | ||
| Q1 25 | $86.5M | $221.1M | ||
| Q4 24 | $84.7M | $218.4M | ||
| Q3 24 | $78.7M | $225.6M | ||
| Q2 24 | $68.7M | $271.7M | ||
| Q1 24 | $77.8M | $282.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $-77.2M | ||
| Q3 25 | $166.7M | $-76.1M | ||
| Q2 25 | $163.7M | $-65.9M | ||
| Q1 25 | $167.1M | $-11.3M | ||
| Q4 24 | $161.0M | $13.4M | ||
| Q3 24 | $162.6M | $13.6M | ||
| Q2 24 | $156.4M | $24.4M | ||
| Q1 24 | $159.7M | $12.7M |
| Q4 25 | $261.1M | $569.7M | ||
| Q3 25 | $264.8M | $573.6M | ||
| Q2 25 | $254.9M | $592.4M | ||
| Q1 25 | $252.7M | $629.4M | ||
| Q4 24 | $240.9M | $664.1M | ||
| Q3 24 | $245.3M | $652.0M | ||
| Q2 24 | $235.8M | $665.3M | ||
| Q1 24 | $247.3M | $662.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $7.7M |
| Free Cash FlowOCF − Capex | $7.6M | $7.6M |
| FCF MarginFCF / Revenue | 6.1% | 6.8% |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $7.7M | ||
| Q3 25 | $18.5M | $2.6M | ||
| Q2 25 | $4.3M | $10.5M | ||
| Q1 25 | $2.6M | $-9.9M | ||
| Q4 24 | $12.2M | $12.5M | ||
| Q3 24 | $9.6M | $9.3M | ||
| Q2 24 | $1.3M | $21.9M | ||
| Q1 24 | $2.2M | $2.0M |
| Q4 25 | $7.6M | $7.6M | ||
| Q3 25 | $16.8M | $2.2M | ||
| Q2 25 | $3.0M | $10.2M | ||
| Q1 25 | $1.5M | $-10.2M | ||
| Q4 24 | $10.0M | $12.0M | ||
| Q3 24 | $7.9M | $9.2M | ||
| Q2 24 | $-2.0M | $21.7M | ||
| Q1 24 | $-1.5M | $1.9M |
| Q4 25 | 6.1% | 6.8% | ||
| Q3 25 | 13.1% | 1.9% | ||
| Q2 25 | 2.6% | 9.1% | ||
| Q1 25 | 1.3% | -9.3% | ||
| Q4 24 | 8.5% | 10.8% | ||
| Q3 24 | 6.9% | 7.8% | ||
| Q2 24 | -1.9% | 17.6% | ||
| Q1 24 | -1.4% | 1.6% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 1.2% | 0.3% | ||
| Q1 25 | 1.0% | 0.3% | ||
| Q4 24 | 1.9% | 0.4% | ||
| Q3 24 | 1.5% | 0.2% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | 3.12× | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
